Ozcan CelebiO. The Diagnostic Accuracy of the Instantaneous Wave-Free Ratio. Angiology. 2021 April 5:33197211006975. doi:10.1177/00033197211006975. Online ahead of print.
2.
VerdoiaMGiosciaRNardinM, et al.Preprocedural b-Blockers in the Functional Assessment of Intermediate Coronary Lesions by Instantaneous Wave-Free Ratio. Angiology. 2021Feb25:3319721996170. doi: 10.1177/0003319721996170. Online ahead of print.
3.
DaviesJESenSDehbiHM, et al.Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med. 2017;376:1824–34.
4.
VerdoiaMGiosciaRSuryapranataHKedhiEDe LucaG; Novara Atherosclerosis Study Group (NAS). Impact of aging on the effects of intracoronary adenosine, peak hyperemia and its duration during fractional flow reserve assessment. Coron Artery Dis. 2021 Jan 18. doi:10.1097/MCA.0000000000001019. Epub ahead of print.
5.
VerdoiaMGiosciaRNardinM, et al.Impact of Age on the Functional Evaluation of Intermediate Coronary Stenoses With Instantaneous Wave-Free Ratio and Fractional Flow Reserve. Angiology. 2021;72:62–9.
6.
López-SendónJSwedbergKMcMurrayJ, et al.and the Task Force on Beta-Blockers of the European Society of Cardiology: Expert consensus document on β-adrenergic receptor blockers. Eur Heart J. 2004;25:1341–62.
7.
WeberMA. The Role of the new beta-blockers in Treating Cardiovascular Disease. Am J Hypertens. 2005;18:169S–76S.
8.
BarbatoE. Role of adrenergic receptors in human coronary vasomotion. Heart. 2009;120:1505–12.
9.
Lund-JohansenPOmvikP. Acute and chronic hemodynamic effects of drugs with different actions on adrenergic receptors: a comparison between alpha blockers and different types of beta blockers with and without vasodilating effect. Cardiovasc Drugs Ther. 1991;5:605–15.
10.
BarbatoESarnoGBerzaCT, et al.Impact of alpha- and beta-adrenergic receptor blockers on fractional flow reserve and index of microvascular resistance. J Cardiovasc Transl Res. 2014;7:803–9.
